E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/11/2015 in the Prospect News PIPE Daily.

Medifocus concludes C$2.13 million private placement of common shares

Non-brokered deal sold 38.75 million common shares at C$0.055 apiece

By Devika Patel

Knoxville, Tenn., May 11 – Medifocus Inc. said it completed a C$2.13 million non-brokered private placement of stock. The deal priced for C$2.23 million on March 27.

The company sold 38.75 million common shares at C$0.055, a 37.5% premium to the March 26 closing share price of C$0.04.

Proceeds will be used for general working capital.

The Burlington, Ont., company is developing minimally invasive, focused-heat tumor targeted cancer treatment devices and systems.

Issuer:Medifocus Inc.
Issue:Common stock
Amount:C$2,131,250
Shares:38.75 million
Price:C$0.055
Warrants:No
Agent:Non-brokered
Pricing date:March 27
Settlement date:May 11
Stock symbol:TSX Venture: MFS
Stock price:C$0.04 at close March 26
Market capitalization:C$5.1 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.